Two drugs to treat "off" times in Parkinson's disease (PD) could be the first MJFF-funded therapies to come to market if approved by the FDA. Also, read about progress for Fox Insight (the Foundation's online clinical study), former Pennsylvania Governer Ed Rendell's life with PD, notable advances in dementia research and trusted fundraising tips.